ArticleDermatology practical & conceptual2020

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab.

Aline Lissa Okita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.